Stay updated on Neratinib for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Neratinib for Metastatic Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Revision v3.5.0 and removed Revision v3.4.3 from the record history.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded revision entry v3.4.3 and removed revision v3.4.2 in the Record History.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed, along with removal of a government funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check71 days agoChange DetectedAdded a government funding lapse notice indicating the NIH Clinical Center is open, and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

- Check78 days agoChange DetectedThe page history adds a 'Show glossary' option and color-coded change highlights (green for additions, red for deletions). The revision label updates from v3.3.4 to v3.4.0.SummaryDifference1%

- Check93 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the v3.3.3 entry was removed; no study data or statuses appear to change.SummaryDifference0.1%

Stay in the know with updates to Neratinib for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.